Changeflow GovPing Pharma & Drug Safety Analyte Detection Immunoassay Patent Grant
Routine Notice Added Final

Analyte Detection Immunoassay Patent Grant

Favicon for changeflow.com USPTO Patent Grants - Peptides (C07K)
Published
Detected
Email

Summary

USPTO granted Promega Corporation patent US12596119B2 covering compositions, kits, and methods for performing analyte detection immunoassays. The patent contains 11 claims and lists inventors Nidhi Nath, Rod Flemming, and Marjeta Urh. The patent application was filed on April 26, 2022.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO issued Patent No. US12596119B2 to Promega Corporation for analyte detection immunoassay technology. The patent covers immunological detection compositions, kits, and methods across multiple CPC classifications including C07K 16/2863 (immunoglobulins), G01N 33/534 (immunoassay processes), and G01N 33/54306 (immunoassay devices). The grant date is April 7, 2026, with application No. 17729829.

Affected parties in the diagnostic, biotechnology, and medical device industries should evaluate this patent when developing similar immunoassay products. Competitors in analyte detection, diagnostic kit manufacturing, and related immunological testing fields may need to consider licensing, design-around options, or freedom-to-operate analysis to avoid infringement on the granted claims.

What to do next

  1. Monitor for patent expiration date (generally 20 years from filing)
  2. Review patent claims for freedom-to-operate analysis
  3. Assess impact on diagnostic product development

Archived snapshot

Apr 7, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Analyte detection immunoassay

Grant US12596119B2 Kind: B2 Apr 07, 2026

Assignee

Promega Corporation

Inventors

Nidhi Nath, Rod Flemming, Marjeta Urh

Abstract

Provided herein are compositions, kits, and methods for performing analyte detection immunoassays.

CPC Classifications

C07K 16/2863 C07K 2317/24 G01N 33/534 G01N 33/54306 G01N 33/58 G01N 33/582 G01N 33/6857 G01N 33/94

Filing Date

2022-04-26

Application No.

17729829

Claims

11

View original document →

Get daily alerts for USPTO Patent Grants - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 7th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12596119B2

Who this affects

Applies to
Manufacturers Healthcare providers Investors
Industry sector
3345 Medical Device Manufacturing
Activity scope
Immunoassay development Diagnostic kit manufacturing Biotech product R&D
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!